<DOC>
	<DOCNO>NCT01700257</DOCNO>
	<brief_summary>Lung cancer number one cancer killer USA . Early stage lung cancer asymptomatic . Most patient lung cancer usually symptomatic diagnosis already advanced stage disease . Low dose CT screening ( LDCT ) high risk individual recently show decrease lung cancer mortality 20 % . However , 4 5 lung cancer death prevent LDCT screen alone .</brief_summary>
	<brief_title>Lung Cancer Screening Study With Low-dose CT Scan Blood Biomarker</brief_title>
	<detailed_description>In trial , addition blood biomarker test combine early LDCT determine screen combination may result detection lung cancer earlier stage disease.The study also assess blood test able detect lung cancer high risk individual LDCT negative cancer . There health-economic cost include final analysis study data .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Smokers former smoker At least 20 pack year history smoking Ages 50 75 Had CT scan chest within last 24 month History cancer within 10 yr ( except skin cancer cervical cancer ) A serious illness decrease life expectancy le 5 year Any current use Oxygen Uncontrolled congestive heart failure cardiac arrhythmia would prevent surgery lung lesion Severe COPD dyspnea would prevent lung surgery stereotactic body radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Lung cancer screen</keyword>
	<keyword>Smokers former smoker</keyword>
	<keyword>Family history lung cancer</keyword>
</DOC>